Taysha Gene Therapies, Inc. TSHA Impairment Charges
Impairment Charges at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsHeldForUse.
The official record: Taysha Gene Therapies, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s impairment charges?
- Taysha Gene Therapies, Inc. (TSHA) reported impairment charges of $0 in Q4 2025.
- What does impairment charges mean?
- Write-downs of long-lived assets (excluding goodwill) when their carrying value exceeds fair value, including property, equipment, right-of-use assets, and other tangible assets.